Bausch Health Companies Inc

1. 01

   Ahead of SPY, behind its sector fund XLV over 1 year

   1 month: +38.5% (SPY −1.6%, XLV +13.5%). 3 months: +32.6% (SPY −0.4%, XLV +15.5%). 1 year: +23.7% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.

   Daily closes, split-adjusted: BHC, SPY and XLV · as of 4 Nov 2026

2. 02

   7.7% below its 52-week high

   Closed at $8.34 on 4 Nov 2026: 7.7% below the 52-week high of $9.04 (30 Oct 2026) and 92.6% above the low of $4.33 (21 Jul 2026).

   Daily price bars, split-adjusted · as of 4 Nov 2026

3. 03

   Above its 50- and 200-day averages

   The 4 Nov 2026 close of $8.34 was 31.8% above its 50-day average ($6.33) and 45.9% above its 200-day average ($5.72). It has closed above the 200-day for 24 sessions, since 2 Oct 2026. The 50-day average crossed above the 200-day on 16 Sep 2026, 35 sessions ago.

   Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026

4. 04

   Volume 2.8× its 30-session average on 30 Oct 2026

   30 Oct 2026 volume of 8.9M shares was 2.8× the average of the 30 sessions before it (3.1M), as the price fell 8.0%. SPY traded 1.9× its own average that session.

   Daily volume against a 30-session baseline · as of 30 Oct 2026

5. 05

   RSI(14) at 71.6, 70 or above

   The 14-session relative strength index closed at 71.6 on 4 Nov 2026, its 2nd session at 70 or above. By convention a reading of 70 or above is called overbought and 30 or below oversold.

   Daily closes, split-adjusted; Wilder's 14-session RSI · as of 4 Nov 2026

At the 4 Nov 2026 close